Sekar Kathiresan - 25 Jul 2022 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Director
Signature
/s/ Brian Adams, as attorney-in-fact
Issuer symbol
RLAY
Transactions as of
25 Jul 2022
Net transactions value
$0
Form type
4
Filing time
27 Jul 2022, 18:57:52 UTC
Previous filing
21 Jul 2022
Next filing
11 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLAY Stock Option (Right to Buy) Award $0 +71,881 $0.000000 71,881 25 Jul 2022 Common Stock 71,881 $20.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments after July 25, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.